We are live on ! Find out more
AIP

ARS Investment Partners Portfolio holdings

AUM $2.29B
1-Year Est. Return 113.95%
This Fund
S&P 500
This Quarter Est. Return
+8.47%
1 Year Est. Return
+113.95%
3 Year Est. Return
+260.1%
5 Year Est. Return
+332.48%
10 Year Est. Return
+1,634.5%
AUM
$776M
AUM Growth
+$52.3M
Cap. Flow
-$2.62M
Cap. Flow %
-0.34%
Top 10 Hldgs %
32.35%
Holding
160
New
11
Increased
54
Reduced
57
Closed
8

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$5.5M
2
CELG
Celgene Corp
CELG
+$5.34M
3
CY
Cypress Semiconductor
CY
+$5.06M
4
BIIB icon
Biogen
BIIB
+$4.64M
5
AMGN icon
Amgen
AMGN
+$3.22M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$8.32M
2
SWKS icon
Skyworks Solutions
SWKS
+$5.72M
3
LOW icon
Lowe's Companies
LOW
+$4.64M
4
IBM icon
IBM
IBM
+$3.45M
5
SPA
Sparton
SPA
+$2.42M

Sector Composition

Rank Sector Weight
1 Technology 27.64%
2 Industrials 12.88%
3 Communication Services 11.38%
4 Healthcare 9.87%
5 Consumer Discretionary 6.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HII icon
126
Huntington Ingalls Industries
HII
$12.6B
$600K 0.08%
2,650
– –
SPA
127
DELISTED
Sparton
SPA
$583K 0.08%
25,117
-104,594
-81% -$2.42M
HD icon
128
Home Depot
HD
$329B
$546K 0.07%
3,339
+23
+0.7% +$3.53K
HDSN
129
Hudson Technologies
HDSN
$249M
$531K 0.07%
68,000
-6,500
-9% -$56.3K
IWV icon
130
iShares Russell 3000 ETF
IWV
$19.5B
$513K 0.07%
3,435
– –
XOM icon
131
ExxonMobil
XOM
$638B
$484K 0.06%
5,909
-70
-1% -$5.56K
NUAN
132
DELISTED
Nuance Communications, Inc.
NUAN
$472K 0.06%
+34,650
New +$495K
GILD icon
133
Gilead Sciences
GILD
$161B
$455K 0.06%
5,610
– –
OME
134
DELISTED
Omega Protein
OME
$450K 0.06%
+27,000
New +$439K
XLU icon
135
State Street Utilities Select Sector SPDR ETF
XLU
$22.9B
$441K 0.06%
16,628
+724
+5% +$19.4K
REM icon
136
iShares Mortgage Real Estate ETF
REM
$535M
$389K 0.05%
8,315
-1,857
-18% -$86.8K
SIGM
137
DELISTED
Sigma Designs Inc
SIGM
$334K 0.04%
+53,000
New +$327K
STL
138
DELISTED
Sterling Bancorp
STL
$301K 0.04%
12,209
– –
GE icon
139
GE Aerospace
GE
$373B
$298K 0.04%
2,574
-13,880
-84% -$1.68M
PG icon
140
Procter & Gamble
PG
$334B
$283K 0.04%
3,115
-7,264
-70% -$661K
NBIX icon
141
Neurocrine Biosciences
NBIX
$16.8B
$276K 0.04%
4,500
– –
AMLP icon
142
Alerian MLP ETF
AMLP
$13B
$267K 0.03%
4,762
-22,528
-83% -$1.29M
PX
143
DELISTED
Praxair Inc
PX
$266K 0.03%
1,900
– –
IBM icon
144
IBM
IBM
$206B
$261K 0.03%
1,884
-24,776
-93% -$3.45M
SBUX icon
145
Starbucks
SBUX
$120B
$255K 0.03%
4,753
-100
-2% -$5.54K
LLY icon
146
Eli Lilly
LLY
$1.02T
$248K 0.03%
2,900
– –
V icon
147
Visa
V
$677B
$243K 0.03%
+2,307
New +$234K
DEO icon
148
Diageo
DEO
$49.1B
$236K 0.03%
1,788
– –
PPLT
149
abrdn Physical Platinum Shares ETF
PPLT
$1.87B
$218K 0.03%
25,000
– –
BKK
150
DELISTED
Blackrock Municipal 2020 Term Trust
BKK
$188K 0.02%
12,000
– –
3 4 5
6
7

Similar funds

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
MA
MCF Advisors Covington, Kentucky $2.28B AUM 14.87% 1-Year Est. Return
ST
Smithfield Trust Pittsburgh, Pennsylvania $2.3B AUM 14.87% 1-Year Est. Return
GCP
Greenoaks Capital Partners Orinda, California $2.3B AUM 19.87% 1-Year Est. Return
LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
LFM
LGT Fund Management Vaduz, Liechtenstein $2.3B AUM 22.66% 1-Year Est. Return

ARS Investment Partners's Q3 2017 Portfolio in Review

As of Q3 2017, ARS Investment Partners held 160 positions worth $776M, up 7.2% from $724M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

ARS Investment Partners's Q3 2017 filing shows 11 new, 54 increased, 57 reduced and 8 closed positions. Its largest new stake was Biogen: 15,671 shares worth $4.91M. The largest sale was Medtronic, an estimated $8.32M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Industrials and Communication Services.

  • ARS Investment Partners's largest Q3 2017 buy was Biogen: 15,671 shares worth $4.91M.
  • ARS Investment Partners added most to Citigroup in Q3 2017, an estimated $5.5M increase.
  • ARS Investment Partners's biggest Q3 2017 reduction was Lowe's Companies, cutting an estimated $4.64M.
  • ARS Investment Partners fully exited Medtronic in Q3 2017, selling an estimated $8.32M.
  • ARS Investment Partners's ten largest holdings make up 32% of its $776M portfolio in Q3 2017.
  • ARS Investment Partners opened 11 new positions and closed 8 in Q3 2017.
  • ARS Investment Partners's portfolio value rose 7.2% quarter-over-quarter to $776M.

Based on ARS Investment Partners's 13F filing for Q3 2017, filed 14 Nov 2017.